New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 12, 2013
05:55 EDTADUS, ADUS, ATRS, ATRS, BGMD, BGMD, DSCO, DSCO, EXPR, EXPR, GSOL, GSOL, KOPN, KOPN, PERI, PERI, SNSS, SNSSCompanies reporting Before the Market Open on Wednesday, March 13
Notable companies reporting before the opening bell on Wednesday include Addus Homecare (ADUS), Antares Pharma (ATRS), BG Medicine (BGMD), Discovery Laboratories (DSCO), Express (EXPR), Global Sources (GSOL), Kopin (KOPN), Perion Network (PERI), and Sunesis Pharmaceuticals (SNSS).
Sign up for a free trial to see the rest of the stories you've been missing.
May 27, 2015
15:30 EDTEXPRNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's open, with earnings consensus, include Toronto-Dominion Bank (TD), consensus $1.11... Signet Jewelers (SIG), consensus $1.63... Flowers Foods (FLO), consensus 30c... Tech Data (TECD), consensus 71c... Sanderson Farms (SAFM), consensus $3.32... Express (EXPR), consensus 14c... Abercrombie & Fitch (ANF), consensus (34c)... Descartes Systems Group (DSGX), consensus 6c... JinkoSolar (JKS), consensus 40c... Fred's (FRED), consensus (1c)... Xcerra (XCRA), consensus 7c... Titan Machinery (TITN), consensus (22c).
14:24 EDTEXPRExpress technical comments ahead of earnings
The key technical feature on the daily chart is a double top pattern that is already in progress. If the news is bearish, the pattern will continue. The downside potential for the pattern is to the $14 area. If the news is bullish, a breakout above the 50-day moving average at $16.85 would void the pattern. Resistance levels to watch as potential upside objectives thereafter would be at $17.75, the 52-week high, and then at $18.90.
13:39 EDTEXPRExpress June volatility elevated into Q1 and outlook
Express June call option implied volatility is at 49, July is at 41, October is at 40; compared to its 52-week range of 28 to 75, suggesting large near term price movement into the expected release of Q1 result on May 28.
May 26, 2015
11:37 EDTEXPRExpress lower promotional activity a good sign for earnings, says Piper Jaffray
Piper Jaffray said its checks indicate Express had only five days in Q1 during which the entire store was discounted, which is down significantly from 20 such days in Q1 of last year, which bodes well for its margins and EPS. The firm believe the company has the potential for significant margin expansion in 2015 and over the next few years and reiterates its Overweight rating and $21 price target on the stock ahead of its Q1 report, which is due on Thursday, May 28.
10:13 EDTEXPRHigh option volume stocks
May 20, 2015
16:23 EDTKOPNKopin appoints Hideki Matsukawa as Chief Display Scientist
Subscribe for More Information
07:36 EDTDSCODiscovery Labs enrolls first patient in Aerosurf Phase 2a dose expansion trial
Subscribe for More Information
May 19, 2015
16:44 EDTBGMDBG Medicine files $75M mixed securities shelf
06:08 EDTADUSAddus HomeCare management to meet with JMP Securities
Meetings to be held in Cleveland on May 20 and in St. Louis on May 21 hosted by JMP Securities.
May 18, 2015
10:01 EDTATRSOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:03 EDTATRSAntares Pharma initiated with an Overweight at Piper Jaffray
Target $3.50.
May 15, 2015
08:24 EDTEXPRAmerican Eagle, Express should be bought ahead of results, says BMO Capital
Subscribe for More Information
May 14, 2015
10:09 EDTEXPRIncreasing equity options volume on open
Increasing equity options volume on open: ONTY CBRL PBYI GWW AXLL IEV KSS EXPR UEC JACK
09:22 EDTDSCOOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Perry Ellis (PERY), up 11.5%... (CTRP), up 13.4%. ALSO HIGHER: AcelRx (ACRX), up 10.3% after being awarded contract worth up to $17M from Defense Dept to advance ARX-04... Oncothyreon (ONTY), up 16.9% after ASCO presentation data released... CYREN (CYRN), up 14.6% after announcing agreement with Dell.... Discovery Laboratories (DSCO), up 5.2% after Aerosurf shows positive Phase 2a data... Kate Spade (KATE), up 3.9% after being initiated with an Outperform at Wedbush. DOWN AFTER EARNINGS: Digital Ally (DGLY), down 16.4%... Kohl's (KSS), down 10.2%... VOXX (VOXX), down 8.1%... Cosi (COSI), down 7.3%. ALSO LOWER: Biotechnology (PBYI), down 15.1%% after Neratinib data published in ASCO abstract... Gevo (GEVO), down 10.7% after 4.3M share Spot Secondary priced at $4.00.
07:49 EDTBGMDBG Medicine reports Q1 EPS (4c), one estimate (3c)
Subscribe for More Information
07:22 EDTSNSSSunesis to present VALOR trial data at ASCO
Subscribe for More Information
07:11 EDTDSCODiscovery Labs's Aerosurf shows positive Phase 2a data
Discovery Laboratories reported top line data from its recently completed Aerosurf phase 2a clinical trial in premature infants with respiratory distress syndrome. Key objectives of the study were achieved, including the primary objective of demonstrating the safety and tolerability of a single exposure of aerosolized KL4 surfactant administered in three escalating inhaled doses to premature infants 29 to 34 week gestational age and receiving nasal continuous positive airway pressure for RDS, and establishing proof of concept for the company's proprietary technology platform. The company plans to start a phase 2a dose expansion in 29 to 34 weeks gestational age infants to evaluate increased doses and repeat dosing in Q2 with completion in Q4, a phase 2a clinical trial assessing the safety and tolerability of escalating doses of AEROSURF administered to 26 to 28 weeks gestational age infants, anticipated to begin in July with completion in Q4, and a phase 2b clinical trial to determine the optimal dose and define the expected efficacy margin of AEROSURF treatment in Q4 with completion in mid 2016.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use